Listed

Elanco Animal Health Inc

ELANNYSECIK 1739104HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.37bn, Q2 FY2026
Net income$54.0m, Q2 FY2026
Elanco Animal Health Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m1,068Revenue, Q3 FY2023, three months to 2023-09-30$1.07bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure1,035Revenue, Q4 FY2023, three months to 2023-12-31$1.03bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure1,205Revenue, Q1 FY2024, three months to 2024-03-31$1.21bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure1,184Revenue, Q2 FY2024, three months to 2024-06-30$1.18bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure1,030Revenue, Q3 FY2024, three months to 2024-09-30$1.03bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure1,020Revenue, Q4 FY2024, three months to 2024-12-31$1.02bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure1,193Revenue, Q1 FY2025, three months to 2025-03-31$1.19bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure1,241Revenue, Q2 FY2025, three months to 2025-06-30$1.24bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure1,137Revenue, Q3 FY2025, three months to 2025-09-30$1.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure1,144Revenue, Q4 FY2025, three months to 2025-12-31$1.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure1,371Revenue, Q1 FY2026, three months to 2026-03-31$1.37bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure1,368Revenue, Q2 FY2026, three months to 2026-06-30$1.37bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure
Cost of revenue$m487Cost of revenue, Q3 FY2023, three months to 2023-09-30$487.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure516Cost of revenue, Q4 FY2023, three months to 2023-12-31$516.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure515Cost of revenue, Q1 FY2024, three months to 2024-03-31$515.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure495Cost of revenue, Q2 FY2024, three months to 2024-06-30$495.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure492Cost of revenue, Q3 FY2024, three months to 2024-09-30$492.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure501Cost of revenue, Q4 FY2024, three months to 2024-12-31$501.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure509Cost of revenue, Q1 FY2025, three months to 2025-03-31$509.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure528Cost of revenue, Q2 FY2025, three months to 2025-06-30$528.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure530Cost of revenue, Q3 FY2025, three months to 2025-09-30$530.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure555Cost of revenue, Q4 FY2025, three months to 2025-12-31$555.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure586Cost of revenue, Q1 FY2026, three months to 2026-03-31$586.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure570Cost of revenue, Q2 FY2026, three months to 2026-06-30$570.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure
Gross profit$mnot reportednot reported690Gross profit, Q1 FY2024, three months to 2024-03-31$690.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure689Gross profit, Q2 FY2024, three months to 2024-06-30$689.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure538Gross profit, Q3 FY2024, three months to 2024-09-30$538.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure519Gross profit, Q4 FY2024, three months to 2024-12-31$519.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure684Gross profit, Q1 FY2025, three months to 2025-03-31$684.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure713Gross profit, Q2 FY2025, three months to 2025-06-30$713.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure607Gross profit, Q3 FY2025, three months to 2025-09-30$607.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure589Gross profit, Q4 FY2025, three months to 2025-12-31$589.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure785Gross profit, Q1 FY2026, three months to 2026-03-31$785.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure798Gross profit, Q2 FY2026, three months to 2026-06-30$798.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure
Research and development$m86.0Research and development, Q3 FY2023, three months to 2023-09-30$86.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure79.0Research and development, Q4 FY2023, three months to 2023-12-31$79.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure87.0Research and development, Q1 FY2024, three months to 2024-03-31$87.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure89.0Research and development, Q2 FY2024, three months to 2024-06-30$89.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure87.0Research and development, Q3 FY2024, three months to 2024-09-30$87.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure81.0Research and development, Q4 FY2024, three months to 2024-12-31$81.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure94.0Research and development, Q1 FY2025, three months to 2025-03-31$94.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure92.0Research and development, Q2 FY2025, three months to 2025-06-30$92.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure89.0Research and development, Q3 FY2025, three months to 2025-09-30$89.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure93.0Research and development, Q4 FY2025, three months to 2025-12-31$93.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure97.0Research and development, Q1 FY2026, three months to 2026-03-31$97.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure92.0Research and development, Q2 FY2026, three months to 2026-06-30$92.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure
Selling, general and administrative$m313Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$313.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure292Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$292.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure337Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$337.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure354Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$354.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure323Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$323.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure300Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$300.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure341Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$341.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure400Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$400.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure351Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$351.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure338Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$338.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure381Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$381.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure449Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$449.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure
Interest expense$m72.0Interest expense, Q3 FY2023, three months to 2023-09-30$72.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure67.0Interest expense, Q4 FY2023, three months to 2023-12-31$67.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-26, accession 0001739104-24-000009. Derived: 12-month figure less the 9-month figure.Report this figure66.0Interest expense, Q1 FY2024, three months to 2024-03-31$66.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-08, accession 0001739104-24-000018.Report this figure65.0Interest expense, Q2 FY2024, three months to 2024-06-30$65.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-08, accession 0001739104-24-000027.Report this figure58.0Interest expense, Q3 FY2024, three months to 2024-09-30$58.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m(1.0)Income tax, Q3 FY2023, three months to 2023-09-30−$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure14.0Income tax, Q4 FY2023, three months to 2023-12-31$14.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure(20.0)Income tax, Q1 FY2024, three months to 2024-03-31−$20.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure18.0Income tax, Q2 FY2024, three months to 2024-06-30$18.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure195Income tax, Q3 FY2024, three months to 2024-09-30$195.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure(43.0)Income tax, Q4 FY2024, three months to 2024-12-31−$43.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure(7.0)Income tax, Q1 FY2025, three months to 2025-03-31−$7.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure14.0Income tax, Q2 FY2025, three months to 2025-06-30$14.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure(16.0)Income tax, Q3 FY2025, three months to 2025-09-30−$16.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure17.0Income tax, Q4 FY2025, three months to 2025-12-31$17.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure30.0Income tax, Q1 FY2026, three months to 2026-03-31$30.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure2.0Income tax, Q2 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure
Net income$m(1,096)Net income, Q3 FY2023, three months to 2023-09-30−$1.10bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure(141)Net income, Q4 FY2023, three months to 2023-12-31−$141.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure32.0Net income, Q1 FY2024, three months to 2024-03-31$32.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure(50.0)Net income, Q2 FY2024, three months to 2024-06-30−$50.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure364Net income, Q3 FY2024, three months to 2024-09-30$364.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure(8.0)Net income, Q4 FY2024, three months to 2024-12-31−$8.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure67.0Net income, Q1 FY2025, three months to 2025-03-31$67.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure11.0Net income, Q2 FY2025, three months to 2025-06-30$11.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure(34.0)Net income, Q3 FY2025, three months to 2025-09-30−$34.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure(276)Net income, Q4 FY2025, three months to 2025-12-31−$276.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure57.0Net income, Q1 FY2026, three months to 2026-03-31$57.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure54.0Net income, Q2 FY2026, three months to 2026-06-30$54.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure
Diluted EPS$ per share(2.22)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$2.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figurenot reported0.06Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure(0.10)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure0.73Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figurenot reported0.13Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure0.02Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure(0.07)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figurenot reported0.11Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure0.11Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure
Basic EPS$ per share(2.22)Basic EPS, Q3 FY2023, three months to 2023-09-30−$2.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figurenot reported0.06Basic EPS, Q1 FY2024, three months to 2024-03-31$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure(0.10)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure0.74Basic EPS, Q3 FY2024, three months to 2024-09-30$0.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figurenot reported0.14Basic EPS, Q1 FY2025, three months to 2025-03-31$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure0.02Basic EPS, Q2 FY2025, three months to 2025-06-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure(0.07)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figurenot reported0.11Basic EPS, Q1 FY2026, three months to 2026-03-31$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure0.11Basic EPS, Q2 FY2026, three months to 2026-06-30$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure

Balance sheet

Cash and equivalents$530.0m, Q2 FY2026
Long-term debt$3.66bn, Q2 FY2026
Shareholders' equity$6.59bn, Q2 FY2026
Elanco Animal Health Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$bn0.4Cash and equivalents, Q3 FY2023, at 2023-09-30$369.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-07, accession 0001739104-23-000023.Report this figure0.4Cash and equivalents, FY2023, at 2023-12-31$352.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-25, accession 0001739104-25-000014.Report this figure0.3Cash and equivalents, Q1 FY2024, at 2024-03-31$345.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0001739104-24-000018.Report this figure0.4Cash and equivalents, Q2 FY2024, at 2024-06-30$416.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001739104-24-000027.Report this figure0.5Cash and equivalents, Q3 FY2024, at 2024-09-30$490.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure0.5Cash and equivalents, FY2024, at 2024-12-31$468.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-24, accession 0001739104-26-000012.Report this figure0.5Cash and equivalents, Q1 FY2025, at 2025-03-31$487.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure0.5Cash and equivalents, Q2 FY2025, at 2025-06-30$539.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure0.5Cash and equivalents, Q3 FY2025, at 2025-09-30$505.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure0.5Cash and equivalents, FY2025, at 2025-12-31$545.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure0.4Cash and equivalents, Q1 FY2026, at 2026-03-31$428.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure0.5Cash and equivalents, Q2 FY2026, at 2026-06-30$530.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure
Current assets$bn3.6Current assets, Q3 FY2023, at 2023-09-30$3.56bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0001739104-23-000023.Report this figure3.4Current assets, FY2023, at 2023-12-31$3.41bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-25, accession 0001739104-25-000014.Report this figure4.1Current assets, Q1 FY2024, at 2024-03-31$4.05bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001739104-24-000018.Report this figure4.0Current assets, Q2 FY2024, at 2024-06-30$4.01bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001739104-24-000027.Report this figure3.4Current assets, Q3 FY2024, at 2024-09-30$3.37bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure3.2Current assets, FY2024, at 2024-12-31$3.21bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-24, accession 0001739104-26-000012.Report this figure3.4Current assets, Q1 FY2025, at 2025-03-31$3.44bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure3.6Current assets, Q2 FY2025, at 2025-06-30$3.61bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure3.5Current assets, Q3 FY2025, at 2025-09-30$3.49bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure3.5Current assets, FY2025, at 2025-12-31$3.46bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure3.6Current assets, Q1 FY2026, at 2026-03-31$3.58bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure3.8Current assets, Q2 FY2026, at 2026-06-30$3.80bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure
Total assets$bn14.3Total assets, Q3 FY2023, at 2023-09-30$14.34bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0001739104-23-000023.Report this figure14.4Total assets, FY2023, at 2023-12-31$14.36bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-25, accession 0001739104-25-000014.Report this figure14.0Total assets, Q1 FY2024, at 2024-03-31$14.02bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001739104-24-000018.Report this figure13.8Total assets, Q2 FY2024, at 2024-06-30$13.76bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001739104-24-000027.Report this figure13.3Total assets, Q3 FY2024, at 2024-09-30$13.28bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure12.6Total assets, FY2024, at 2024-12-31$12.61bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-24, accession 0001739104-26-000012.Report this figure12.9Total assets, Q1 FY2025, at 2025-03-31$12.94bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure13.7Total assets, Q2 FY2025, at 2025-06-30$13.74bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure13.6Total assets, Q3 FY2025, at 2025-09-30$13.55bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure13.4Total assets, FY2025, at 2025-12-31$13.36bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure13.2Total assets, Q1 FY2026, at 2026-03-31$13.22bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure13.6Total assets, Q2 FY2026, at 2026-06-30$13.56bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure
Current liabilities$bn1.3Current liabilities, Q3 FY2023, at 2023-09-30$1.26bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0001739104-23-000023.Report this figure1.2Current liabilities, FY2023, at 2023-12-31$1.24bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-25, accession 0001739104-25-000014.Report this figure1.2Current liabilities, Q1 FY2024, at 2024-03-31$1.23bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001739104-24-000018.Report this figure1.4Current liabilities, Q2 FY2024, at 2024-06-30$1.37bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001739104-24-000027.Report this figure1.3Current liabilities, Q3 FY2024, at 2024-09-30$1.32bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure1.3Current liabilities, FY2024, at 2024-12-31$1.31bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-24, accession 0001739104-26-000012.Report this figure1.3Current liabilities, Q1 FY2025, at 2025-03-31$1.27bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure1.4Current liabilities, Q2 FY2025, at 2025-06-30$1.39bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure1.5Current liabilities, Q3 FY2025, at 2025-09-30$1.46bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure1.6Current liabilities, FY2025, at 2025-12-31$1.60bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure1.7Current liabilities, Q1 FY2026, at 2026-03-31$1.66bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure1.9Current liabilities, Q2 FY2026, at 2026-06-30$1.85bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure
Total liabilities$bn8.2Total liabilities, Q3 FY2023, at 2023-09-30$8.21bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0001739104-23-000023.Report this figure8.1Total liabilities, FY2023, at 2023-12-31$8.14bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-25, accession 0001739104-25-000014.Report this figure8.0Total liabilities, Q1 FY2024, at 2024-03-31$7.96bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001739104-24-000018.Report this figure7.8Total liabilities, Q2 FY2024, at 2024-06-30$7.82bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001739104-24-000027.Report this figure6.8Total liabilities, Q3 FY2024, at 2024-09-30$6.76bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure6.5Total liabilities, FY2024, at 2024-12-31$6.52bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-24, accession 0001739104-26-000012.Report this figure6.6Total liabilities, Q1 FY2025, at 2025-03-31$6.59bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure7.0Total liabilities, Q2 FY2025, at 2025-06-30$6.97bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure6.8Total liabilities, Q3 FY2025, at 2025-09-30$6.80bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure6.8Total liabilities, FY2025, at 2025-12-31$6.81bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure6.7Total liabilities, Q1 FY2026, at 2026-03-31$6.72bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure7.0Total liabilities, Q2 FY2026, at 2026-06-30$6.97bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure
Long-term debt$bn5.9Long-term debt, Q3 FY2023, at 2023-09-30$5.87bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-07, accession 0001739104-23-000023.Report this figure5.7Long-term debt, FY2023, at 2023-12-31$5.74bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-25, accession 0001739104-25-000014.Report this figure5.7Long-term debt, Q1 FY2024, at 2024-03-31$5.73bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-08, accession 0001739104-24-000018.Report this figure5.5Long-term debt, Q2 FY2024, at 2024-06-30$5.46bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-08, accession 0001739104-24-000027.Report this figure4.3Long-term debt, Q3 FY2024, at 2024-09-30$4.31bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure4.3Long-term debt, FY2024, at 2024-12-31$4.28bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure4.4Long-term debt, Q1 FY2025, at 2025-03-31$4.35bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure4.0Long-term debt, Q2 FY2025, at 2025-06-30$3.95bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure3.8Long-term debt, Q3 FY2025, at 2025-09-30$3.77bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure3.8Long-term debt, FY2025, at 2025-12-31$3.76bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure3.7Long-term debt, Q1 FY2026, at 2026-03-31$3.74bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure3.7Long-term debt, Q2 FY2026, at 2026-06-30$3.66bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure
Current portion of debt$bn0.0Current portion of debt, Q3 FY2023, at 2023-09-30$39.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-07, accession 0001739104-23-000023.Report this figure0.0Current portion of debt, FY2023, at 2023-12-31$38.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-25, accession 0001739104-25-000014.Report this figure0.0Current portion of debt, Q1 FY2024, at 2024-03-31$38.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-08, accession 0001739104-24-000018.Report this figure0.2Current portion of debt, Q2 FY2024, at 2024-06-30$213.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-08, accession 0001739104-24-000027.Report this figure0.0Current portion of debt, Q3 FY2024, at 2024-09-30$44.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure0.0Current portion of debt, FY2024, at 2024-12-31$44.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure0.0Current portion of debt, Q1 FY2025, at 2025-03-31$44.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figurenot reportednot reportednot reportednot reportednot reported
Shareholders' equity$bn6.1Shareholders' equity, Q3 FY2023, at 2023-09-30$6.13bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure6.2Shareholders' equity, FY2023, at 2023-12-31$6.22bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-24, accession 0001739104-26-000012.Report this figure6.1Shareholders' equity, Q1 FY2024, at 2024-03-31$6.06bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure5.9Shareholders' equity, Q2 FY2024, at 2024-06-30$5.94bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure6.5Shareholders' equity, Q3 FY2024, at 2024-09-30$6.52bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure6.1Shareholders' equity, FY2024, at 2024-12-31$6.10bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure6.4Shareholders' equity, Q1 FY2025, at 2025-03-31$6.35bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure6.8Shareholders' equity, Q2 FY2025, at 2025-06-30$6.78bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure6.7Shareholders' equity, Q3 FY2025, at 2025-09-30$6.75bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure6.5Shareholders' equity, FY2025, at 2025-12-31$6.55bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure6.5Shareholders' equity, Q1 FY2026, at 2026-03-31$6.50bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure6.6Shareholders' equity, Q2 FY2026, at 2026-06-30$6.59bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure

Cash flow

Operating cash flow$277.0m, Q2 FY2026
Capital expenditure$33.0m, Q2 FY2026
Elanco Animal Health Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m198Operating cash flow, Q3 FY2023, three months to 2023-09-30$198.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001739104-24-000039. Derived: 9-month figure less the 6-month figure.Report this figure157Operating cash flow, Q4 FY2023, three months to 2023-12-31$157.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure2.0Operating cash flow, Q1 FY2024, three months to 2024-03-31$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure200Operating cash flow, Q2 FY2024, three months to 2024-06-30$200.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001739104-25-000055. Derived: 6-month figure less the 3-month figure.Report this figure162Operating cash flow, Q3 FY2024, three months to 2024-09-30$162.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001739104-25-000071. Derived: 9-month figure less the 6-month figure.Report this figure177Operating cash flow, Q4 FY2024, three months to 2024-12-31$177.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure(4.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure237Operating cash flow, Q2 FY2025, three months to 2025-06-30$237.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001739104-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure219Operating cash flow, Q3 FY2025, three months to 2025-09-30$219.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001739104-25-000071. Derived: 9-month figure less the 6-month figure.Report this figure108Operating cash flow, Q4 FY2025, three months to 2025-12-31$108.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure13.0Operating cash flow, Q1 FY2026, three months to 2026-03-31$13.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure277Operating cash flow, Q2 FY2026, three months to 2026-06-30$277.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001739104-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m33.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$33.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001739104-24-000039. Derived: 9-month figure less the 6-month figure.Report this figure41.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$41.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure24.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$24.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure34.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$34.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001739104-25-000055. Derived: 6-month figure less the 3-month figure.Report this figure42.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$42.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001739104-25-000071. Derived: 9-month figure less the 6-month figure.Report this figure47.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$47.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure65.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$65.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure57.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$57.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001739104-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure92.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$92.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001739104-25-000071. Derived: 9-month figure less the 6-month figure.Report this figure62.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$62.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001739104-26-000012. Derived: 12-month figure less the 9-month figure.Report this figure51.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$51.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure33.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$33.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001739104-26-000043. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)505.90m, Q2 FY2026
Elanco Animal Health Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares488Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30488,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0001739104-23-000023.Report this figure493Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31492,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001739104-24-000018.Report this figure493Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30492,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001739104-24-000027.Report this figure493Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30492,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001739104-24-000039.Report this figure496Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31496,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0001739104-25-000042.Report this figure494Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30494,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001739104-25-000055.Report this figure498Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30497,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure499Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31499,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure500Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30500,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure497Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30496,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001739104-25-000071.Report this figure506Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31506,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001739104-26-000030.Report this figure506Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30505,900,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure

Shares outstanding: 499.62mShares outstanding, period not labelled, at 2026-08-03499,621,830 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001739104-26-000043.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.